From: Yijing Decoction improves premature ovarian failure in rats by activating VEGF/VEGFR-2/FAK pathway
Group | Pregnancy rate (%) | Average number of implantation sites | Number of live births | Body weight of newborn rats (g) | Â |
---|---|---|---|---|---|
Control | 90.00% (9/10) | 16.67 ± 0.58 | 15.67 ± 1.22 | 7.62 ± 0.14 | |
TP | 42.86% (3/7) | 9.33 ± 1.53*** | 9.33 ± 1.53*** | 6.87 ± 0.25*** | |
TP + L-YJD | 50.00% (4/8) | 12.33 ± 0.58 | 12.00 ± 0.41### | 7.00 ± 0.17## | |
TP + M-YJD | 62.50% (5/8) | 14.00 ± 0.00## | 12.40 ± 1.14### | 7.31 ± 0.16### | |
TP + H-YJD | 57.14% (4/7) | 12.33 ± 0.58# | 11.75 ± 0.96## | 7.01 ± 0.25# | |
TP + DHEA | 77.78% (7/9) | 15.00 ± 1.00### | 14.71 ± 1.38###& | 7.41 ± 0.20###&& |